Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU672694B2 - Tissue characterisation using intravascular echoscopy - Google Patents
[go: Go Back, main page]

AU672694B2 - Tissue characterisation using intravascular echoscopy - Google Patents

Tissue characterisation using intravascular echoscopy Download PDF

Info

Publication number
AU672694B2
AU672694B2 AU65325/94A AU6532594A AU672694B2 AU 672694 B2 AU672694 B2 AU 672694B2 AU 65325/94 A AU65325/94 A AU 65325/94A AU 6532594 A AU6532594 A AU 6532594A AU 672694 B2 AU672694 B2 AU 672694B2
Authority
AU
Australia
Prior art keywords
pixel
attenuation slope
artery
sight
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU65325/94A
Other versions
AU6532594A (en
Inventor
Habib Emile Talhami
Laurence Sydney Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AU65325/94A priority Critical patent/AU672694B2/en
Priority claimed from PCT/AU1994/000200 external-priority patent/WO1994023652A1/en
Publication of AU6532594A publication Critical patent/AU6532594A/en
Application granted granted Critical
Publication of AU672694B2 publication Critical patent/AU672694B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Ultra Sonic Daignosis Equipment (AREA)

Description

C:\1\SPECS\PATENT\PC\ A-9006A.WPD -22/7/96 -1- TITLE: "TISSUE CHARACTERISATION USING INTRAVASCULAR ECHOSCOPY" Technical Field This invention concerns tissue characterisation. More particularly, it concerns the characterisation of vascular tissue using intravascular echoscopy. The present invention relates to a measurement technique involving intravascular ultrasound echoscopy, followed by a display of a parameter which has been called the "ultrasound attenuation slope" within the tissue of human arteries. Observation of variations in the ultrasound attenuation slope in different parts of the walls of the arteries assists in the diagnosis of the presence of plaque degeneration in the vascular tissue.
Background to the Invention It is well known that ultrasound echoscopy may be used for imaging blood vessels from within the vessel, using an intravascular ultrasonic transducer. The ultrasound imaging instruments used in intravascular echoscopy generally have a 3600 field of view, and the image of the vessel (usually an artery) is presented in cross-sectional format. Thus, in intravascular echoscopy, all S of the ultrasound lines of sight of the transducer usually intersect the vessel wall at, or close to, right angles. The intravascular transducer may be rotated mechanically to scan the ultrasound 20 lines of sight, but a 3600 scan pattern (required to form a complete image, and generally termed an ultrasound "frame") can also be produced by using a transducer having an array of transducer elements, and using phase delays and/or selective activation of the transducer elements to move the ultrasound line of sight around the circularly symmetrical scan pattern.
25 In primates, one feature of healthy arterial tissue is that it contains no plaque (deposits on the artery wall). Plaque, in one of its various types, is caused by arterial disease. Intravascular echoscopy measurements performed at any location within the artery using ultrasould lines of sight in different radial directions will not necessarily exhibit any variation of ultrasound attenuation through the arterial tissue due to the presence of plaque on the artery wall, although s the plaque always changes the appearance of the artery in the ultrasound image. Only -ft^ wilfWW--' C,\'0\1\SPECS\PATENPCT\LA-9006A.WPD -22/7/96 -2non-fibrous plaque (that is, degenerative plaque) changes the ultrasound transmission characteristic in the region of the plaque.
Disclosure of the Present Invention The prime objective of the present invention is to provide a method and apparatus whereby changes in the properties of vascular tissue, which are associated with degenerative processes in plaque, may be detected and displayed.
This objective is achieved by performing intravascular ultrasound echoscopy of the arterial i tissue and monitoring the frequency content of the ultrasound echoes produced by backscatter from the tissue in the arterial wall, including the plaque, and simultaneously displaying, on a conventional intravascular echoscopy display, the variation of frequency content (a parameter termed "the attenuation slope") and information about the size of ultrasonic echoes from the I tissue region. j Now it is known that the spectrum of the backscattered ultrasound (that is, the ultrasonic energy that is reflected from acoustic discontinuities in tissue) is affected by the phenomenon known as frequency dependent attenuation. Frequency dependent attenuation is the preferential removal of energy from the higher frequencies of the ultrasound beam generated by the i 20 transducer as that beam propagates through the tissue. The change in frequency content as the 1 ultrasound beam traverses the tissue is measured by recording the echoes from each line of sight in digital form, dividing the recorded echoes into shorter segments, and calculating a number S: characteristic of the frequenc:, c.ontent of the spectrum of the echoes from each region. As |shown by L S Wilson, D E Robinson and B D Doust in their paper entitled "Frequency Domain S" 25 Processing for Ultrasonic Attenuation Measurement in Liver", published in Ultrasonic Imaging, volume 6, pages 278-292 (1984), one suitable measure of the frequency content of ultrasoni- Si.o echoes is "spectral slope", which is the slope of a straight line fitted by least squares regression to the logarithm of the power spectrum of the ultrasonic echoes. However, other parameters, such as the average frequency of the ultrasonic echoes, may be used equally effectively as an indication of the frequency content of the echoes from each short segment "window" of an
S:)
C\W \SPECS\PATENT CI\A-9006A.WPD 22/7/96 -3 ultrasound line of sight. For convenience, the indication of the frequency content, however calculated, will be termed the "spectral characteristic number".
When adopting this technique as part of the present invention, the spectral characteristic number is preferably calculated along every ultrasound line of sight of the transducer during a complete revolution, but in many instances adequate information can be obtained from the spectral characteristic numbers from a subset of the lines of sight (for example, from every second line of sight, or every third line of sight). If the intravascular transducer is translated along the axis t of the artery while this technique is being used, calculations of the spectral characteristic number are carried out over several scan revolutions, and the data obtained refer to a volume of tissue rather than to a two-dimensional area. The spectral characteristic numbers are considered in small groups of at least two along each ultrasound line of sight. These groups may overlap. The centre of each group is identified with a specific location in the interrogated tissue. A measure of the rate of change with depth of the frequency content is calculated from each group. This measure is calculated as a simple difference if there are only two members in each group, and is preferably calculated as the slope of a least squares regression line of best fit of the frequency content representations of the groups when there are more than two spectral characteristic numbers in each group. Each of S. 20 these calculated rates of change (now known as the "attenuation slopes") is associated with a .i particular location in the tissue. Thus the attenuation slope data can be presented on a grid which, in general, will be coarser than the array of pixels comprising the conventional grey scale image.
25 Thus, according to the present invention, there is provided a method for use in detecting and displaying areas of degeneration of plaque in an artery of a subject, the method comprising the steps of positioning an intravascular ultrasonic transducer at a predetermined location in an I artery of the subject; ]a b) recording, in digital form, all of the received echoes of ultrasound energy received from .v ii Aw C:\'1\SPECS\PATNT'PCr ,A-9006A.WPD 22/7/96 -4a predetermined number of ultrasound lines of sight during at least one rotational scan of the lines of sight of the transducer; selecting a plurality of windows located at a regular spacing down each line of sight and computing, for each window in each line of sight, from the radiofrequency form of the received ultrasound echoes, a spectral characteristic number, the value of which represents the spectral content of echo signals within each window; for each line of sight, forming the spectral characteristic numbers into groups, each group containing the spectral characteristic numbers in respect of a plurality of adjacent windows, and computing an attenuation slope for each group, the attenuation slope being the local rate of change of the spectral characteristic numbers; forming, in a digital buffer, an array of pixel values, the value of each pixel in the array corresponding to the average of a number of adjacent attenuation slope values calculated in step independently of steps and forming, from the radiofrequency data in respect of i each window, a conventional image of the artery in which the intensity (brightness) of each pixel in the image is proportional to the amplitude of the ultrasound echoes received from the corresponding piece of tissue; and determining whether each average attenuation slope pixel value calculated in step (e) S. exceeds a predetermined threshold value (or a respective one of a predetermined set of I: 20 threshold values), and if the (or the lowest) threshold attenuation slope value is not exceeded, displaying the grey scale pixel calculated in step on a conventional output display device of the echoscope; and if the average attenuation slope pixel value exceeds ;the threshold attenuation slope value (or a respective one of the predetermined set of attenuation slope threshold values), displaying on said output display device a pixel in, a form which is different from the normal image pixel display.
4 a. V Another aspect of the present invention is the incorporation of the attenuation slope data into S the image of a conventional grey scale intravascular echoscope. This instrument produces an image of the vessel that is being examined, using a grey scale representation of echo size. The S grey scale image is combined with the attenuation slope image in the following manner. At
N
CC:\W\'IPEcs\ATEN~xPCr\LA-9006A.AD 22/7N •a 4 or f.a f 14..
cr each grey level pixel in the image, the average of the attenuation slopes at several of the nearest points to that pixel is calculated. If the resulting attenuation slope is less than a predetermined threshold, only the normal grey level of the image is displayed. However, if the predetermined attenuation slope threshold is exceeded, the corresponding pixel is displayed as a colour other than black or white or scales of grey (the normal display hue), with the hue of the colour directly related to the calculated average, in the region of the pixel, of the attenuation slopes. In addition, the brightness of the display is made to be proportional to the grey scale level corresponding to that pixel in the conventional grey scale display. Thus the attenuation slope information is combined with the grey scale information in a single echoscope display.
This type of display can be used in the detection of areas of degenerative plaque because such areas have a higher attenuation slope than other vascular tissue. With suitable setting of a number of attenuation slope thresholds, such areas will be displayed as colou red regions on an otherwise grey scale image. Because the brightness of the coloured area is modulated by the underlying grey scale, simultaneous display of both the attenuation slope and the echo size at a region of tissue is achieved.
Preferably, several colour hues will be used in the display, each indicating when a respective predetermined threshold of attenuation slope value has been exceeded. However, in a simple (but nevertheless effective) implementation of the present invention, only one colour (hue), in addition to the normal grey level display colour, may be used.
The second aspect ofthe present invention encompasses apparatus for detecting and displaying areas of degenerative plaque in an artery of a subject, the apparatus comprising: 25 reception means for receiving and recording, in digital form, radiofrequency echo signals of ultrasound energy received, by an intravascular ultrasonic transducer that has been positioned at a predetermined location in an artery of a subject, following transmission of ultrasound by said transducer along a predetermined number of lines of sight; selection means for selecting a plurality of windows located at a regular spacing down each line of sight and computing, for each window in each line of sight, from the l, iet i
II
L
I n
F-
C SPECS\PATENTCI\LA-9006A.WPD -22/7/96 -6radiofrequency form of the received ultrasound echoes, a spectral characteristic number, the value of which represents the spectral content of echo signals within each window; computation means for forming the spectral characteristic numbers for each line of sight into groups, each group containing the spectral characteristic numbers in respect of a plurality of adjacent windows, and (ii) computing the attenuation slope for each group; i a digital buffer adapted to receive data from said computation means and to form therefrom an array of pixel values, the value of each pixel in the array corresponding to the average of a number of adjacent attenuation slope values calculated in said computation means; imaging means for forming, from the radiofrequency data in respect of each window, a conventional image of the artery in which the intensity (brightness) of each pixel in the image is proportional to the amplitude of the ultrasound echoes received from the corresponding piece of tissue; and comparison means, for determining whether each average attenuation slope pixel value calculated in said digital buffer exceeds a predetermined threshold value (or a respective one of a predetermined set of threshold values), and if the (or the lowest) threshold attenuation slope value is not exceeded, displaying the grey scale pixel calculated by 6 4 said imaging means on a conventional output display device of the echoscope; and if the .t 20 average attenuation slope pixel value exceeds the threshold attenuation slope value (or u "1 a respective one of the predetenrined set of attenuation slope threshold values), displaying on said output display device a pixel in a form which is different from the :normal image pixel display.
,4 I 25 For a fuller understanding of the present invention, an embodiment of each aspect of the invention, provided by way of example only, will now be described with reference to the accompanying drawings.
I t* t Brief Description of the Drawings J0 Figure 1 is a schematic diagram of an intravascular ultrasonic transducer which is positioned
A
C\V'l\SPECS\PATENTPC\LA-9006A.WPD 22/17/96 -7within an artery containing a region of calcified artery wall, during diastole.
Figure 2 depicts the components and features of Figure 1 during systole.
Figure 3 is a partly schematic, partly block diagram, illustration of one form of apparatus for monitoring the elasticity of an artery wall.
Figure 4 is a partly schematic, partly block diagram illustration of intravascular ultrasonic echoscopy equipment, modified in accordance with the present invention to display regions of degenerative plaque in an artery wall.
Detailed Description of the Illustrated Embodiments i Figure 1 shows, schematically, an intravascular ultrasonic transducer 10 positioned within an i artery 15 having a substantially uniform thickness of its wall 12 during diastole. Samples of lines of sight 13 are shown intersecting the artery wall 12 substantially at right angles. The lines of sight 13 are the directions in which ultrasonic energy from the transducer 10 is directed, and along which echoes of that ultrasonic energy are received from acoustic discontinuities. The received echoes are used to form an ultrasonic image. Only a representative number of the lines of sight are shown in Figure 1.
eKl:": Figure 2 illustrates the changes that occur to the arrangement shown in Figure 1 later in the cardiac cycle, when the condition of the artery 15 changes from diastol to systole. The blood ;pressure within the artery has increased and the internal diameter of the artery has increased.
The thickness of the arterial wall 12 has been reduced except at the region 14. In the region 14, 25 the artery wall has been stiffened as a result of calcification. (In practice, the regions of an arterial wall which have become calcified undergo less thinning than a normal, healthy arterial i wall during systole, rather than as shown in Figure 2 no thinning at all.) Apparatus to perform detection of arterial wall calcification is shown, partly in block diagram orm, in Figure 3. Although this apparatus is shown in Figure as a separate module from the
C)
C:\'0\'lSPECS\PATENT\PCTLA-9006A.WPD- 22/7/96 -8conventional intravascular scanner 35 (which produces the image shown schematically on display 36), it may be incorporated into a conventional intravasculai ecaioscope.
To investigate the elasticity of the artery wall of a subject, using the apparatus shown in Figure 2, data is obtained by sequentially scanning through the ultrasonic lines of sight during at least one cardiac cycle of the subject. This data consists of lines of sight ultrasound echoes data, in digital form. It may be obtained directly from the received echoes of each line of sight, as radio frequency data, through a data path 17 connected to the receiver circuits in the scanner.
Alternatively, it may be calculated from images which have been formed in the conventional scanner 35, extracted through a data path 18.
Although the data obtained by the latter method has a reduced quality compared to data obtained directly from the receiver circuits of the scanner, it is more convenient to use the images in the scanner when the apparatus is an independent module which is to be connected Lo an essentially i unmodified intravascular scanner. It requires a frame grabber 19 which converts images in television video form into digitally stored images. The output of the frame grabber 19 is S. connected to a module 20 which converts the video frame image into lines of sight data (that is, S into data representing one-dimensional arrays of brightness calculated along lines of sight radiating at equal angular intervals from the location of the transducer in the images). Those S 20 proficient in this art will recognise that module 20 acts as an x-y to r-O conversion module.
The lines of sight data are stored in a memory 21 in such a way that they may be accessed according to the three indexing variables depth (that is, distance from the transducer), azimuth S (that is, the direction in which the line of sight is pointing) and time (that is, from which S 25 ultrasound frame the data was recorded). In general, it will be necessary to record all data before processing it.
The data is processed by a stage 24 which windows in depth so that only data from the artery wall is analysed. It is possible to have a plurality of windows along one line of sight to I easure deformations at different depths within the artery wall, (ii) a single window defining
LU
1 1 ii INTERNATIONAL SEARCH RPORT International application No.
PCT/AU 94/00200 Box I Observations where certain claims wert an -archable (Continuvtion of Item 1 of first sheet) This international search report has not established in resp ,rtain claims under Article 17(2)(a) for the following reasons: 1. r-1 Claims Nos.: f C:\'V1\SPECS\PATENC\PLA-9006A.WPD 22/796 -9the artery wall, or (iii) a window which effectively includes the whole of the data. The following description refers to an embodiment of the invention ir. which a single window is used for each azimuth position.
Each windowed data segment is transformed using a Fourier or Chirp Z transform stage 25 to produce a power spectrum over a range of frequencies. This range of frequencies is chosen to include most of the energy present in the original line of sight. The next stage (26) performs the calculation of a measure of the dominant frequency present in the spectrum.
The processing within the combination of stages 24, 25 and 26 (shown as box 22 in Figure 3) is repeated for every data frame, so that the time evolution of the data segment is analysed. The data output from box 22 consists of a one-dimensional array of numbers, each of which represents a characteristic frequency for a different ultrasound frame. A median filter 27 applied to the buffer removes apparent frequency shifts not associated with tissue deformations.
The or",ation of the median filter 27 has been described above.
The two modules 28 and 29 compute an average Q, and a measure of spread Q 2 (such as a root mean square), respectively, of the smoothed array of frequencies output from the median filter 27 for each line of sight ultrasound frame. A divider module 30 computes the ratio of the spread 20 to the mean value, QJ/Q, which represents the variation in fractional deformation of the tissue.
If the basic data has been obtained over two or more cardiac cycles of the subject, improved averaging will be achieved.
j In the arrangement shown in Figure 3, the ratio QJ/Q 1 is computed for each azimuthal position, 25 and for each window along the line of sight if a plurality of windows has been employed for each line of sight.
S! At the completion of the calculation of Q/QI for each location, a special display 31 shows bcth the conventional ultrasound image 32 (which may be selected from the images recorded in the frame grabber) and the deformation of the artery wall for each position where it has been 0 1 C\'V1\SPECS\PATENT\PCLA-9DO6AWPD 2/796 10- I calculated. This deformation display may be any one of a number of possible forms, such as a graph 33 of deformation arranged in a concentric fashion around the image of the vessel, or the application to the image 32 of colours whose hue or saturation corresponds to the amount of deformation.
Figure 4 shows an intravascular ultrasonic transducer 41 located within an artery 42 and producing an image in the scan plane 43. A typical ultrasound line of sight 44 is shown. The ultrasonic echoes 45 from acoustic discontinuities in the path of the beam transmitted along each i line of sight in a complete (3600) revolution (scan) of the beam(s) produced by the transducer 41 are recorded in digital form, at a sufficiently high sampling rPte that they are also recorded in radiofrequency form. The echoes 45 from each line of sight 44 are broken into short segments and the data in each segment are multiplied by a suitable window 46 (such as a Hamming window) in module 420. Each windowed data segment passes through a processor 421 which calculates the Fourier transform of the data segment and converts the result to a i| logarithmic power spectrum form, of which a sequence of six successive spectra are shown at 47. A further module 422 calculates the slope of a straight line 48 of best fit to each of the power spectra. The slope of the straight line 48 is the "spectral slope" or a "spectral S" characteristic number" of the data from its associated window.
b 20 The array of spectral slopes is then divided (in module 423) into groups of two or three and a series of lines of best fit 49 are calculated. The slopes of these lines 49 are the "attenuation slopes" referred to earlier in this specification. These attenuation slopes pass through a scan converter module 424 which calculates the position in space corresponding to each attenuation S slope computed by the spatial gradient module 423. The s:an converter module 424 also S1 I 25 smooths the result by replacing each value by the average of itself and a group of neighbouring values. Because the value of each attenuation slope is calculated on a coarser grid than that 0o. ,4 normally used for imaging, missing values have been calculated by interpolation between the i attenuation slope values which are calculated by the above method.
The result of these calculations is a two-dimensional array of numbers, the value of each of L fJ j* C:\'I\SPECS\PATENI\PCMA-9006A.WD 22/7/96 -11- which corresponds to the local attenuation slope of the tissue, shown in the drawing as grey levels in an image 410. However, it should be noted that these grey levels are not actually displayed when the illustrated embodiment of the invention is used.
The radiofrequency echoes also pass through a module 411 which computes a conventional grey scale image from the ultrasonic echoes. The scan converter stage 412 used in this processing computes grey scale values (based on echo size), using the same grid as the attenuation slope image. The image produced by the output from the module 412 is shown as image 413, but the image 413 is not necessarily displayed when the illustrated embodiment of the invention is used.
A combined image 414 is formed from the grey scale image 413 by calculating a new coloured pixel value at each location. The hue (colour) of each pixel in the combined image 414 indicates whether the attenuation slope value determined for the corresponding tissue location is above, or below, a threshold value (or one of a series of threshold values). The brightness (intensity) of each pixel in the combined image 414 is calculated from the grey scale image 413.
The user of the illustrated equipment may be given the option of viewing the grey scale image 413, the combined coloured image 414, or both of these images at the same time in a side-byof a side format.
20 The presence of a colour, other than the normal display grey values, in the image 414 provides C ,an immediate indication of the presence of degenerative plaque in the vascular tissue which is imaged by the intravascular echoscopy equipment.
t t Those familiar with intravascular ultrasonic echoscopy will appreciate that variations and 25 modifications of the illustrated and described embodiments of the two aspects of this invention may be made without departing from the present inventive concepts.
I it i L I R 1 L 7{ 0" 0i

Claims (8)

1. A method for use in detecting and displaying areas of degeneration of plaque in an artery of a subject, said method comprising the steps of positioning an intravascular ultrasonic transducer at a predetermined location in an artery of the subject; recording, in digital form, all of the received echoes of ultrasound energy j received from a predetermined number of ultrasound lines of sight during at least i one rotational scan of the lines of sight of the transducer; selecting a plurality of windows located at a regular spacing down each line of sight and computing, for each window in each line of sight, from the radiofrequency form of the received ultrasound echoes, a spectral characteristic number, the value of which represents the spectral content of echo signals within each window; for each line of sight, forming the spectral characteristic numbers into groups, each group containing the spectral characteristic numbers in respect of a plurality of adjacent windows, and computing the attenuation slope for each group, the attenuation slope being the local rate c. change of the spectral characteristic numbers; forming, in a digital buffer, an array of pixel values, the value of each pixel in t •the array corresponding to the average of a number of adjacent attenuation slope values calculated in step a: independently of steps and forming, from the radiofrequency data in respect of each window, a conventional image of the artery in which the intensity (brightness) of each pixel in the image is proportional to the amplitude of the ultrasound echoes received from the corresponding piece of tissue; and e. i determining whether each average attenuation slope pixel value calculated in step exceeds a predetermined threshold value, or a respective one of a predetermined set of threshold values, and if the, or the lowest, threshold ©ST q attenuation slope value is not exceeded, displaying the grey scale pixel 7A i 1 C:\'1WSPECS\PATEN\PCIA-9006A.WPD 22/7 6 -13 calculated in step on a conventional output display device of the echoscope; or (ii) if the average attenuation slope pixel value exceeds the threshold attenuation slope value, or a respective one of the predetermined set of attenuation slope threshold values, displaying on said output display device a pixel in a form which is different from the normal image pixel.
2. A method as defined in claim 1, in which said display which is different from the normal image pixel is either a colour which is different from the normal pixel colour, or (ii) a colour which is selected from a plurality of different colours, each of which is representative of a respective range of values of the attenuation slope, between thresholds in a predetermined set of attenuation slope threshold values.
3. A method as defined in claim 1 or claim 2, in which the attenuation slope for each group of spectral characteristic numbers is computed by determining the difference between the spectral characteristic numbers when there are two spectral characteristic numbers in the group, and by calculating the slope of a least squares regression line for the Sspectral characteristic numbers when there are more than two spectral characteristic numbers per group.
4. A method as defined in claim 1, claim 2 or claim 3, in which said intravascular :i transducer is moved along the axis of the artery during the performance of the method.
5. Apparatus for detecting and displaying areas of degenerative plaque in an artery of a *4 subject, said apparatus comprising: echo signals of ultrasound energy received, by an intravascular ultrasonic Ss transducer that has been positioned at a predetermined location in an artery of a subject, following transmission of ultrasound by said transducer along a predetermined number of lines of sight; r selection means for selecting a plurality of windows located at a regular spacing 5. Apaau fo eetn n ipaigaeso egnrtv lqei natr fa CV\' \SPBCS\PATENT\PC LA-9006A.WPD 22f7/6 S14- down each line of sight and computing, for each window in each line of sight, from the radiofrequency form of the received ultrasound echoes, a spectral characteristic number, the value of which represents the spectral content of echo signals within each window; computation means for forming the spectral characteristic numbers for each line of sight into groups, each group containing the spectral characteristic numbers in respect of a plurality of adjacent windows, and (ii) computing the attenuation slope for each group; S g a digital buffer adapted to receive data from said computation means and to form therefrom an array of pixel values, the value of each pixel in the array corresponding to the average of a number of adjacent attenuation slope values i 4 calculated in said computation means; imaging means for forming, from the radiofrequency data in respect of each 1 window, a conventional image of the artery in which the intensity (brightness) of each pixel in the image is proportional to the amplitude of the ultrasound echoes received from the corresponding piece of tissue; and i comparison means, for determining whether each average attenuation slope pixel ;value calculated in said digital buffer exceeds a predetermined threshold value (or a respective one of a predetermined set of threshold values), and if the (or the lowest) threshold attenuation slope value is not exceeded, displaying the grey scale pixel calculated by said imaging means on a conventional output display device of the echoscope; and if the average attenuation slope pixel value exceeds the threshold attenuation slope value (or a respective one of the predetermined S. set of attenuation slope threshold values), displaying on said output display i 2" device a pixel in a form which is different from the normal image pixel display.
6. Apparatus as defined in claim 5, in which said display which is different from the normal image pixel is either a colour which is different from the normal pixel colour, or (ii) a colour which is selected from a plurality of different colours, each of which is ST representative of a respective range of values of the attenuation slope, between z f "t I i i iAle C:\''l\SPECS\PATENITPCTILA-9006A.WPD 22/7/96 15 thresholds in a predetermined set of attenuation slope threshold values.
7. A method for use in detecting and displaying areas of degeneration of plaque in an artery of a subject, substantially as hereinbefore described with reference to Figure 4 of the accompanying drawings.
8. Apparatus for detecting and displaying areas of degenerative plaque in an artery of a subject, as hereinbefore described with reference to Figure 4 of the accompanying drawings. DATED this twenty-second day of July 1996 CSIRO By DAVIES COLLISON CAVE Registered Patent Attorneys for the Applicant(s) o, C t a t 44 ¢t v 4 tti i Ii i C:VO\'I\SPBCS\PATENT\PCmA-9006A.WPD 22/7/96 ABSTRACT The presence of degenerative plaque on an artery are two symptoms of arterial disease. The presence of degenerative plaque is determined using intravascular echoscopy and monitoring the frequency content of echoes produced by backscatter from the tissue in the artery wall. The parameter known as the "attenuation slope" of the ultrasound echoes is used as a measure of their frequency content. The values of this parameter are displayed on the conventional grey scale image of the artery cross-section at the point of measurement. 4 o a. a a *la I a. a a, Ia a 9b IS a a a a. a S I I *4I I Ia I a a a ala. I a t alt~ aatt I II at a. at aa~. I 4141 a. at. a. I I I a t& a a
AU65325/94A 1993-04-19 1994-04-18 Tissue characterisation using intravascular echoscopy Expired - Fee Related AU672694B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU65325/94A AU672694B2 (en) 1993-04-19 1994-04-18 Tissue characterisation using intravascular echoscopy

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPL8345 1993-04-19
AUPL834593 1993-04-19
AUPL848893 1993-04-23
AUPL8488 1993-04-23
PCT/AU1994/000200 WO1994023652A1 (en) 1993-04-19 1994-04-18 Tissue characterisation using intravascular echoscopy
AU65325/94A AU672694B2 (en) 1993-04-19 1994-04-18 Tissue characterisation using intravascular echoscopy

Publications (2)

Publication Number Publication Date
AU6532594A AU6532594A (en) 1994-11-08
AU672694B2 true AU672694B2 (en) 1996-10-10

Family

ID=27155584

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65325/94A Expired - Fee Related AU672694B2 (en) 1993-04-19 1994-04-18 Tissue characterisation using intravascular echoscopy

Country Status (1)

Country Link
AU (1) AU672694B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1426687A (en) * 1973-04-18 1976-03-03 Siemens Ag Mean frequency measurement and its application to monitoring the motion of matter
US4844083A (en) * 1985-09-26 1989-07-04 Kabushiki Kaisha Toshiba Ultrasonic imaging apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1426687A (en) * 1973-04-18 1976-03-03 Siemens Ag Mean frequency measurement and its application to monitoring the motion of matter
US4844083A (en) * 1985-09-26 1989-07-04 Kabushiki Kaisha Toshiba Ultrasonic imaging apparatus

Also Published As

Publication number Publication date
AU6532594A (en) 1994-11-08

Similar Documents

Publication Publication Date Title
US5417215A (en) Method of tissue characterization by ultrasound
JP5715594B2 (en) Method and apparatus for flow parameter imaging
US8597191B2 (en) Ultrasonic imaging apparatus and a method of generating ultrasonic images
USRE38209E1 (en) Diagnostic ultrasound system
WO1994023652A1 (en) Tissue characterisation using intravascular echoscopy
US9901323B2 (en) Aberration correction using channel data in ultrasound imaging system
JP3746115B2 (en) Ultrasonic diagnostic equipment
US4575799A (en) Ultrasonic living body tissue characterization system
EP1005834B1 (en) Method and apparatus for automatic doppler angle estimation in ultrasound imaging
US5361767A (en) Tissue characterization method and apparatus
JP2791255B2 (en) Ultrasound color Doppler tomography
US7871379B2 (en) Ultrasonic diagnostic apparatus and method of ultrasonic measurement
US4658827A (en) Ultrasound scanner for tissue characterization
EP1008863B1 (en) Method and apparatus for automatic transmit waveform optimization in B-mode ultrasound imaging
JP7449957B2 (en) Quantification measurement of three-dimensional volumetric flow rate
US5419332A (en) Mapping of flow parameters
WO2016108178A1 (en) Method for quantifying the elasticity of a material by ultrasounds
JPH08173422A (en) Ultrasonic diagnostic equipment
US4803994A (en) Backscatter data collection technique for ultrasound
JP2007222253A (en) Blood flow image display device
US7371219B2 (en) Ultrasound diagnosis apparatus operable in doppler mode
US8795181B2 (en) System and method for analyzing carpal tunnel using ultrasound imaging
AU672694B2 (en) Tissue characterisation using intravascular echoscopy
JP3349672B2 (en) Ultrasound diagnostic equipment
JPH05317312A (en) Ultrasonic diagnosing apparatus